Pete the Herring was one of thousands who took part in the trials of dexamethasone, which has been shown to reduce the number of deaths in critically ill people with COVID-19.
Development hailed as a significant step forwardat the Oxford University School which is conducting the trial saying “what we saw was really quite remarkable”.
Mr. Herring, 69, told Sky News that her condition was so bad that doctors at the Edenbrooke Hospital had spoken of placing her in an induced coma if the drug under test had not been effective.
He said, “It’s touch and go at one point. I was really bad.
“I had several symptoms of the flu, but he had trouble breathing which was the worst.
“I was admitted to the hospital on April 28 and moved to intensive care within an hour.
“I have been on oxygen the whole time I was there and it got to the point where they talked about putting me in an artificial coma.
“I knew I was on the trial, but I didn’t know at the time if I had been on the drug, or just a placebo.
“My recovery was really little by little. It was not like someone flicking a switch and I was fine. ”
He said doctors have given him a CPAP mask, a device normally used as therapy for sleep apnea syndrome.
“Maybe it was a combination of that and the drugs,” he said.
“I’m not sure how much of an idea anyone really had of how much effect everyone had. ”
After being discharged from the hospital on May 6, he said he learned that he had been given the trial drug weeks later.
“I am 100% grateful that I was part of the trial, and it is wonderful news that this drug seems to work,” he said.
:: Listen to the podcast on Apple Podcasts, Google Podcasts, Spotify, Spreaker
“Since then I have learned that it is actually quite inexpensive that the drugs go in the sense that it will be available to developing countries, which is also good to know. ”
Mr. de Harengs, from Ely, Cambridgeshire, said his time at the hospital had been difficult for his family, including his son, daughter, two grandchildren and a partner he lived with.
“My partner was a rock, but it was horrible for my whole family,” he says.
The drug has been found to reduce death rates by around 35% for patients on ventilators, and by around 20% for those who need oxygen.
Professor Peter Horby, who led the drug test, said on Tuesday at Downing Street briefing that he registers “intensive care patients” with COVID-19.